Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran
- 1 November 2001
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 20 (50) , 7368-7374
- https://doi.org/10.1038/sj.onc.1204912
Abstract
Extremely high rates of squamous cell carcinoma of the esophagus (SCCE) are observed in Iran, reflecting unknown, genetic and/or epidemiological risk factors. Among genetic alterations in SCCE, TP53 mutations are the most frequent, vary among populations, and may provide clues on etiological mechanisms. We have analysed mutations in TP53 (exons 5-8) in 98 SCCE from Iran by temporal temperature gel electrophoresis and direct sequencing. We found 58 mutations in 49 patients (50%), with a high prevalence of C to T transitions at CpG dinucleotides (29.3%). The TP53 mutation pattern in Iran was significantly different from that observed in SCCEs from high incidence areas of China and Western Europe (P=0.007). Moreover, the prevalence of mutations at A : T base pairs (transitions and transversions) was higher in men than in women (38.7% vs 11.1%, P=0.033). COX-2 overexpression was detected in 69% of the cases evaluated (24/35), without significant association with TP53 mutation. Accumulation of nitrotyrosine, a marker of protein damage by excess levels of nitric oxide, was observed in tumor cells in six of 18 [corrected] cases analysed. These results are consistent with the hypothesis that several factors are involved in TP53 mutagenesis in Iran. These factors include a baseline of chronic inflammatory stress, which may have a multiplicative impact on the sensitivity of esophageal cells to exogenous factors of risk.Keywords
This publication has 27 references indexed in Scilit:
- Molecular and Clinical Differences between Adenocarcinomas of the Esophagus and of the Gastric CardiaThe American Journal of Pathology, 2001
- Nitric Oxide Nitrates Tyrosine Residues of Tumor-Suppressor p53 Protein in MCF-7 CellsBiochemical and Biophysical Research Communications, 2000
- Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesionsCarcinogenesis: Integrative Cancer Research, 1999
- Inactivation of the p53 protein in cell lines derived from human esophageal cancersInternational Journal of Cancer, 1997
- ACCELERATED PAPER: Immunohistoselective sequencing (IHSS) of P 53 tumor suppressor gene in human oesophageal precancerous lesionsCarcinogenesis: Integrative Cancer Research, 1996
- p53 mutations in esophageal tumors from high-incidence areas of ChinaInternational Journal of Cancer, 1995
- Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1994
- Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomasMolecular Carcinogenesis, 1993
- Characterization and identification of 6 mutagens in opium pyrolysates implicated in oesophagel cancer in IranMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1985
- INGESTED MUTAGENS FROM OPIUM AND TOBACCO PYROLYSIS PRODUCTS AND CANCER OF THE ŒSOPHAGUSThe Lancet, 1978